(NP (NP (NP Nuclear/JJ association/NN) (PP of/IN (NP a/DT T-cell/NN transcription/NN factor/NN)) (VP blocked/VBN (NP */-NONE-) (PP by/IN (NP-LGS-COOD (NP FK-506/NN) and/CC (NP cyclosporin/NN A/NN))))) (PRN -LCB-/-LRB- (S (NP-SBJ */-NONE-) (VP see/VB (NP comments/NNS))) -RCB-/-RRB-))
(S (NP-SBJ-COOD (NP Cyclosporin/NN A/NN) and/CC (NP FK506/NN)) (VP inhibit/VBP (NP (NP-COOD (NP (ADJP-COOD (ADJP T-/NN (NP *?*/-NONE-)) and/CC (ADJP B-cell/NN)) activation/NN) and/CC (NP other/JJ processes/NNS)) (ADJP essential/JJ (PP to/TO (NP an/DT effective/JJ immune/JJ response/NN))))) ./.)
(S (PP In/IN (NP T/NN lymphocytes/NNS)) (NP-SBJ these/DT drugs/NNS) (VP disrupt/VBP (NP (NP an/DT unknown/JJ step/NN) (PP in/IN (NP (NP the/DT transmission/NN) (PP of/IN (NP signals/NNS)) (PP from/IN (NP the/DT T-cell/NN antigen/NN receptor/NN)) (PP to/TO (NP (NP cytokine/NN genes/NNS) (SBAR (WHNP-24 that/WDT) (S (NP-SBJ *T*-24/-NONE-) (VP coordinate/VBP (NP the/DT immune/JJ response/NN)))))))))) ./.)
(S (NP-SBJ (NP The/DT putative/JJ intracellular/JJ receptors/NNS) (PP for/IN (NP-COOD (NP FK506/NN) and/CC (NP cyclosporin/NN)))) (VP are/VBP (NP-PRD cis-trans/JJ prolyl/JJ isomerases/NNS)) ./.)
(S-COOD (S (NP-SBJ (NP Binding/NN) (PP of/IN (NP the/DT drug/NN))) (VP inhibits/VBZ (NP isomerase/NN activity/NN))) ,/, but/CC (S (NP-SBJ-COOD (NP (NP studies/NNS) (PP with/IN (NP other/JJ prolyl/JJ isomerase/NN inhibitors/NNS))) and/CC (NP (NP analysis/NN) (PP of/IN (NP (NP cyclosporin-resistant/JJ mutants/NNS) (PP in/IN (NP yeast/NN)))))) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ (NP the/DT effects/NNS) (PP of/IN (NP the/DT drug/NN))) (VP result/VBP (PP-COOD (PP from/IN (NP (NP the/DT formation/NN) (PP of/IN (NP an/DT inhibitory/JJ complex/NN)) (PP between/IN (NP-COOD (NP the/DT drug/NN) and/CC (NP isomerase/NN))))) ,/, and/CC (PP not/RB from/IN (NP (NP inhibition/NN) (PP of/IN (NP isomerase/NN activity/NN)))))))))) ./.)
(S (NP-SBJ-104 (NP (NP A/DT transcription/NN factor/NN) ,/, (NP NF-AT/NN) ,/,) (SBAR (WHNP-27 which/WDT) (S (NP-SBJ *T*-27/-NONE-) (VP is/VBZ (ADJP-PRD essential/JJ (PP for/IN (NP early/JJ T-cell/NN gene/NN activation/NN)))))) ,/,) (VP seems/VBZ (S (NP-SBJ *-104/-NONE-) (VP to/TO (VP be/VB (NP-PRD (NP a/DT specific/JJ target/NN) (PP of/IN (NP (NP-COOD (NP cyclosporin/NN A/NN) and/CC (NP FK506/NN)) action/NN))) (SBAR because/IN (S (NP-SBJ-25 (NP transcription/NN) (VP directed/VBN (NP */-NONE-) (PP by/IN (NP-LGS this/DT protein/NN)))) (VP is/VBZ (VP blocked/VBN (NP *-25/-NONE-) (PP in/IN (NP (NP T/NN cells/NNS) (VP treated/VBN (NP */-NONE-) (PP with/IN (NP these/DT drugs/NNS))))) ,/, (PP with/IN (NP (NP (QP little/JJ or/CC no/DT) effect/NN) (PP on/IN (NP (NP other/JJ transcription/NN factors/NNS) (PP such/JJ as/IN (NP-COOD (NP AP-1/NN) and/CC (NP NF-kappa/NN B/NN))))))))))))))) ./.)
(S (ADVP Here/RB) (NP-SBJ we/PRP) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ-26 NF-AT/NN) (VP is/VBZ (VP formed/VBN (NP *-26/-NONE-) (SBAR-TMP (WHADVP-28 when/WRB) (S (NP-SBJ-29 (NP a/DT signal/NN) (PP from/IN (NP the/DT antigen/NN receptor/NN))) (VP (VP-COOD (VP induces/VBZ (NP a/DT pre-existing/JJ cytoplasmic/JJ subunit/NN) (S (NP-SBJ *-29/-NONE-) (VP to/TO (VP translocate/VB (PP to/TO (NP the/DT nucleus/NN)))))) and/CC (VP combine/VB (PP with/IN (PP (NP a/DT (ADJP newly/RB synthesized/VBN) nuclear/JJ subunit/NN) (PP of/IN (NP NF-AT/NN)))))) (ADVP *T*-28/-NONE-))))))))) ./.)
(S (NP-SBJ-COOD-30 (NP FK506/NN) and/CC (NP cyclosporin/NN A/NN)) (VP block/VBP (NP (NP translocation/NN) (PP of/IN (NP the/DT cytoplasmic/JJ component/NN))) (PP without/IN (S (NP-SBJ *-30/-NONE-) (VP affecting/VBG (NP (NP synthesis/NN) (PP of/IN (NP the/DT nuclear/JJ subunit/NN))))))) ./.)
